Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03710109 · ClinicalTrials.gov registry record

Evaluation of an EEG Based Concussion System

A clinical trial of Concussion, sponsored by Icahn School of Medicine at Mount Sinai.

Recruiting
Registry status
150
Enrollment target
2
Study locations

NCT03710109 is a study of Concussion that is actively recruiting participants, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 150 participants, above the 129-participant average among 9 other Concussion trials with a reported enrollment target (16% higher). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03710109, a study of Concussion, is actively recruiting participants, sponsored by Icahn School of Medicine at Mount Sinai.

RECRUITING
Registry status
150 participants
Enrollment target
2
Study locations

Study Summary

This study will evaluate the accuracy of a new concussion system at detecting concussions. The investigators will be evaluating the degree to which data collected with the device agrees with a physician's determination of a concussion. The system captures an electroencephalograph (EEG) potential when a light is flashed into the eyes of an individual. The device is not FDA approved, but it is a non-significant risk device. The device is a non-invasive, non-interventional sensor. It will not replace the opinion of the physician in diagnosing a concussion. This study will test the EEG based concussion system on 200 individuals, Participants will be made up of individuals who are seeking medical consultation at the Play Safe Concussion Clinic (10 Union Square E, New York, NY 10003) or at Mount Sinai Hospital (1468 Madison Ave, New York, NY 10029) after experiencing a head trauma. The Play Safe Clinic treats patients who reach out to Mount Sinai Physicians via the Play Safe telephone number: 212 241 2221. The doctors who see patients these locations will be involved in conducting this research. In addition to the standard-of-care clinical assessments, participants will also receive an evaluation from the concussion based system. When a subject experiences a head trauma, the subject will be evaluated for a concussion by both the standard-of-care clinical assessments. The treating physician will provide all necessary standard-of-care evaluations and diagnostic procedures needed to properly diagnose and treat each patient and by the new concussion system. The researchers will also collect data from healthy, age-matched controls in order to collect a database of healthy responses to the technology. To determine how accurate the new concussion system is at detecting concussions, the research team will compare the diagnostic results from the device to the diagnostic results of the doctor's assessments. The goal of this study is to develop a device that can give sound advice

Conditions Studied

Interventions

  • OTHER EEG

Study Locations (2)

New York

  • Mount Sinai Beth Israel Hospital - New York
  • Abilities Research Center - New York

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2018-10-23
Est. Completion 2025-12-03

What the Registry Record Tells You About NCT03710109

The ClinicalTrials.gov registry entry for NCT03710109 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 129-participant average among 9 other Concussion trials with a reported enrollment target (16% higher). The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Concussion appearing as the primary indexed condition, and to 1 intervention - of which EEG is the first listed.

NCT03710109 reports 2 study locations spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT03710109 about?

NCT03710109 is a clinical study titled "Evaluation of an EEG Based Concussion System". This study will evaluate the accuracy of a new concussion system at detecting concussions. The investigators will be evaluating the degree to which data collected with the device agrees with a physician's determination of a concussion. The system captures an electroencephalograph (EEG) potential whe...

What is the current status of trial NCT03710109?

This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2018-10-23. Estimated completion is 2025-12-03.

What conditions does trial NCT03710109 study?

This clinical trial studies the following conditions: Concussion.

What interventions are being tested in trial NCT03710109?

The interventions under investigation include: EEG (OTHER).

Who is sponsoring clinical trial NCT03710109?

This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03710109 being conducted?

This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Concussion

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.